Global Influenza Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.
The Global Influenza Therapeutics Market Size was estimated at USD 7201.62 million in 2023 and is projected to reach USD 9541.09 million by 2029, exhibiting a CAGR of 4.80% during the forecast period.
This report provides a deep insight into the global Influenza Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Therapeutics market in any manner.
Global Influenza Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Astrazeneca PLC
Biocryst Pharmaceuticals, Inc.
Chiron Corporation
CSL Limited
Daiichi Sankyo Co., Ltd.
Glaxosmithkline PLC
Mitsubishi Tanabe Pharma Corporation
Nanotherapeutics Inc.
Protein Sciences Corporation
Roche Holding AG
Sanofi SA
Shionogi & Co., Ltd.
Sinovac Biotech Ltd.
Market Segmentation (by Type)
Vaccines
Drugs
Market Segmentation (by Application)
Hospitals
Clinic
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.
The Global Influenza Therapeutics Market Size was estimated at USD 7201.62 million in 2023 and is projected to reach USD 9541.09 million by 2029, exhibiting a CAGR of 4.80% during the forecast period.
This report provides a deep insight into the global Influenza Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Therapeutics market in any manner.
Global Influenza Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Astrazeneca PLC
Biocryst Pharmaceuticals, Inc.
Chiron Corporation
CSL Limited
Daiichi Sankyo Co., Ltd.
Glaxosmithkline PLC
Mitsubishi Tanabe Pharma Corporation
Nanotherapeutics Inc.
Protein Sciences Corporation
Roche Holding AG
Sanofi SA
Shionogi & Co., Ltd.
Sinovac Biotech Ltd.
Market Segmentation (by Type)
Vaccines
Drugs
Market Segmentation (by Application)
Hospitals
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Influenza Therapeutics Market
- Overview of the regional outlook of the Influenza Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Influenza Therapeutics
1.2 Key Market Segments
1.2.1 Influenza Therapeutics Segment by Type
1.2.2 Influenza Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Influenza Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Influenza Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Influenza Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Influenza Therapeutics Sales Sites, Area Served, Product Type
3.6 Influenza Therapeutics Market Competitive Situation and Trends
3.6.1 Influenza Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFLUENZA THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Influenza Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFLUENZA THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Influenza Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Influenza Therapeutics Price by Type (2019-2024)
7 INFLUENZA THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Therapeutics Market Sales by Application (2019-2024)
7.3 Global Influenza Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Influenza Therapeutics Sales Growth Rate by Application (2019-2024)
8 INFLUENZA THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Influenza Therapeutics Sales by Region
8.1.1 Global Influenza Therapeutics Sales by Region
8.1.2 Global Influenza Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Influenza Therapeutics Basic Information
9.1.2 Abbott Laboratories Influenza Therapeutics Product Overview
9.1.3 Abbott Laboratories Influenza Therapeutics Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Influenza Therapeutics SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Astrazeneca PLC
9.2.1 Astrazeneca PLC Influenza Therapeutics Basic Information
9.2.2 Astrazeneca PLC Influenza Therapeutics Product Overview
9.2.3 Astrazeneca PLC Influenza Therapeutics Product Market Performance
9.2.4 Astrazeneca PLC Business Overview
9.2.5 Astrazeneca PLC Influenza Therapeutics SWOT Analysis
9.2.6 Astrazeneca PLC Recent Developments
9.3 Biocryst Pharmaceuticals, Inc.
9.3.1 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Basic Information
9.3.2 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Overview
9.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Market Performance
9.3.4 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics SWOT Analysis
9.3.5 Biocryst Pharmaceuticals, Inc. Business Overview
9.3.6 Biocryst Pharmaceuticals, Inc. Recent Developments
9.4 Chiron Corporation
9.4.1 Chiron Corporation Influenza Therapeutics Basic Information
9.4.2 Chiron Corporation Influenza Therapeutics Product Overview
9.4.3 Chiron Corporation Influenza Therapeutics Product Market Performance
9.4.4 Chiron Corporation Business Overview
9.4.5 Chiron Corporation Recent Developments
9.5 CSL Limited
9.5.1 CSL Limited Influenza Therapeutics Basic Information
9.5.2 CSL Limited Influenza Therapeutics Product Overview
9.5.3 CSL Limited Influenza Therapeutics Product Market Performance
9.5.4 CSL Limited Business Overview
9.5.5 CSL Limited Recent Developments
9.6 Daiichi Sankyo Co., Ltd.
9.6.1 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Basic Information
9.6.2 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Overview
9.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Market Performance
9.6.4 Daiichi Sankyo Co., Ltd. Business Overview
9.6.5 Daiichi Sankyo Co., Ltd. Recent Developments
9.7 Glaxosmithkline PLC
9.7.1 Glaxosmithkline PLC Influenza Therapeutics Basic Information
9.7.2 Glaxosmithkline PLC Influenza Therapeutics Product Overview
9.7.3 Glaxosmithkline PLC Influenza Therapeutics Product Market Performance
9.7.4 Glaxosmithkline PLC Business Overview
9.7.5 Glaxosmithkline PLC Recent Developments
9.8 Mitsubishi Tanabe Pharma Corporation
9.8.1 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Basic Information
9.8.2 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
9.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Market Performance
9.8.4 Mitsubishi Tanabe Pharma Corporation Business Overview
9.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
9.9 Nanotherapeutics Inc.
9.9.1 Nanotherapeutics Inc. Influenza Therapeutics Basic Information
9.9.2 Nanotherapeutics Inc. Influenza Therapeutics Product Overview
9.9.3 Nanotherapeutics Inc. Influenza Therapeutics Product Market Performance
9.9.4 Nanotherapeutics Inc. Business Overview
9.9.5 Nanotherapeutics Inc. Recent Developments
9.10 Protein Sciences Corporation
9.10.1 Protein Sciences Corporation Influenza Therapeutics Basic Information
9.10.2 Protein Sciences Corporation Influenza Therapeutics Product Overview
9.10.3 Protein Sciences Corporation Influenza Therapeutics Product Market Performance
9.10.4 Protein Sciences Corporation Business Overview
9.10.5 Protein Sciences Corporation Recent Developments
9.11 Roche Holding AG
9.11.1 Roche Holding AG Influenza Therapeutics Basic Information
9.11.2 Roche Holding AG Influenza Therapeutics Product Overview
9.11.3 Roche Holding AG Influenza Therapeutics Product Market Performance
9.11.4 Roche Holding AG Business Overview
9.11.5 Roche Holding AG Recent Developments
9.12 Sanofi SA
9.12.1 Sanofi SA Influenza Therapeutics Basic Information
9.12.2 Sanofi SA Influenza Therapeutics Product Overview
9.12.3 Sanofi SA Influenza Therapeutics Product Market Performance
9.12.4 Sanofi SA Business Overview
9.12.5 Sanofi SA Recent Developments
9.13 Shionogi and Co., Ltd.
9.13.1 Shionogi and Co., Ltd. Influenza Therapeutics Basic Information
9.13.2 Shionogi and Co., Ltd. Influenza Therapeutics Product Overview
9.13.3 Shionogi and Co., Ltd. Influenza Therapeutics Product Market Performance
9.13.4 Shionogi and Co., Ltd. Business Overview
9.13.5 Shionogi and Co., Ltd. Recent Developments
9.14 Sinovac Biotech Ltd.
9.14.1 Sinovac Biotech Ltd. Influenza Therapeutics Basic Information
9.14.2 Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
9.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Product Market Performance
9.14.4 Sinovac Biotech Ltd. Business Overview
9.14.5 Sinovac Biotech Ltd. Recent Developments
10 INFLUENZA THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Influenza Therapeutics Market Size Forecast
10.2 Global Influenza Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Therapeutics Market Size Forecast by Region
10.2.4 South America Influenza Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Influenza Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Influenza Therapeutics by Type (2025-2030)
11.1.2 Global Influenza Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Influenza Therapeutics by Type (2025-2030)
11.2 Global Influenza Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Influenza Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Influenza Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Influenza Therapeutics
1.2 Key Market Segments
1.2.1 Influenza Therapeutics Segment by Type
1.2.2 Influenza Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Influenza Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Influenza Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Influenza Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Influenza Therapeutics Sales Sites, Area Served, Product Type
3.6 Influenza Therapeutics Market Competitive Situation and Trends
3.6.1 Influenza Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFLUENZA THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Influenza Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFLUENZA THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Influenza Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Influenza Therapeutics Price by Type (2019-2024)
7 INFLUENZA THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Therapeutics Market Sales by Application (2019-2024)
7.3 Global Influenza Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Influenza Therapeutics Sales Growth Rate by Application (2019-2024)
8 INFLUENZA THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Influenza Therapeutics Sales by Region
8.1.1 Global Influenza Therapeutics Sales by Region
8.1.2 Global Influenza Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Influenza Therapeutics Basic Information
9.1.2 Abbott Laboratories Influenza Therapeutics Product Overview
9.1.3 Abbott Laboratories Influenza Therapeutics Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Influenza Therapeutics SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Astrazeneca PLC
9.2.1 Astrazeneca PLC Influenza Therapeutics Basic Information
9.2.2 Astrazeneca PLC Influenza Therapeutics Product Overview
9.2.3 Astrazeneca PLC Influenza Therapeutics Product Market Performance
9.2.4 Astrazeneca PLC Business Overview
9.2.5 Astrazeneca PLC Influenza Therapeutics SWOT Analysis
9.2.6 Astrazeneca PLC Recent Developments
9.3 Biocryst Pharmaceuticals, Inc.
9.3.1 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Basic Information
9.3.2 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Overview
9.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Market Performance
9.3.4 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics SWOT Analysis
9.3.5 Biocryst Pharmaceuticals, Inc. Business Overview
9.3.6 Biocryst Pharmaceuticals, Inc. Recent Developments
9.4 Chiron Corporation
9.4.1 Chiron Corporation Influenza Therapeutics Basic Information
9.4.2 Chiron Corporation Influenza Therapeutics Product Overview
9.4.3 Chiron Corporation Influenza Therapeutics Product Market Performance
9.4.4 Chiron Corporation Business Overview
9.4.5 Chiron Corporation Recent Developments
9.5 CSL Limited
9.5.1 CSL Limited Influenza Therapeutics Basic Information
9.5.2 CSL Limited Influenza Therapeutics Product Overview
9.5.3 CSL Limited Influenza Therapeutics Product Market Performance
9.5.4 CSL Limited Business Overview
9.5.5 CSL Limited Recent Developments
9.6 Daiichi Sankyo Co., Ltd.
9.6.1 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Basic Information
9.6.2 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Overview
9.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Market Performance
9.6.4 Daiichi Sankyo Co., Ltd. Business Overview
9.6.5 Daiichi Sankyo Co., Ltd. Recent Developments
9.7 Glaxosmithkline PLC
9.7.1 Glaxosmithkline PLC Influenza Therapeutics Basic Information
9.7.2 Glaxosmithkline PLC Influenza Therapeutics Product Overview
9.7.3 Glaxosmithkline PLC Influenza Therapeutics Product Market Performance
9.7.4 Glaxosmithkline PLC Business Overview
9.7.5 Glaxosmithkline PLC Recent Developments
9.8 Mitsubishi Tanabe Pharma Corporation
9.8.1 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Basic Information
9.8.2 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
9.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Market Performance
9.8.4 Mitsubishi Tanabe Pharma Corporation Business Overview
9.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
9.9 Nanotherapeutics Inc.
9.9.1 Nanotherapeutics Inc. Influenza Therapeutics Basic Information
9.9.2 Nanotherapeutics Inc. Influenza Therapeutics Product Overview
9.9.3 Nanotherapeutics Inc. Influenza Therapeutics Product Market Performance
9.9.4 Nanotherapeutics Inc. Business Overview
9.9.5 Nanotherapeutics Inc. Recent Developments
9.10 Protein Sciences Corporation
9.10.1 Protein Sciences Corporation Influenza Therapeutics Basic Information
9.10.2 Protein Sciences Corporation Influenza Therapeutics Product Overview
9.10.3 Protein Sciences Corporation Influenza Therapeutics Product Market Performance
9.10.4 Protein Sciences Corporation Business Overview
9.10.5 Protein Sciences Corporation Recent Developments
9.11 Roche Holding AG
9.11.1 Roche Holding AG Influenza Therapeutics Basic Information
9.11.2 Roche Holding AG Influenza Therapeutics Product Overview
9.11.3 Roche Holding AG Influenza Therapeutics Product Market Performance
9.11.4 Roche Holding AG Business Overview
9.11.5 Roche Holding AG Recent Developments
9.12 Sanofi SA
9.12.1 Sanofi SA Influenza Therapeutics Basic Information
9.12.2 Sanofi SA Influenza Therapeutics Product Overview
9.12.3 Sanofi SA Influenza Therapeutics Product Market Performance
9.12.4 Sanofi SA Business Overview
9.12.5 Sanofi SA Recent Developments
9.13 Shionogi and Co., Ltd.
9.13.1 Shionogi and Co., Ltd. Influenza Therapeutics Basic Information
9.13.2 Shionogi and Co., Ltd. Influenza Therapeutics Product Overview
9.13.3 Shionogi and Co., Ltd. Influenza Therapeutics Product Market Performance
9.13.4 Shionogi and Co., Ltd. Business Overview
9.13.5 Shionogi and Co., Ltd. Recent Developments
9.14 Sinovac Biotech Ltd.
9.14.1 Sinovac Biotech Ltd. Influenza Therapeutics Basic Information
9.14.2 Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
9.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Product Market Performance
9.14.4 Sinovac Biotech Ltd. Business Overview
9.14.5 Sinovac Biotech Ltd. Recent Developments
10 INFLUENZA THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Influenza Therapeutics Market Size Forecast
10.2 Global Influenza Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Therapeutics Market Size Forecast by Region
10.2.4 South America Influenza Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Influenza Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Influenza Therapeutics by Type (2025-2030)
11.1.2 Global Influenza Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Influenza Therapeutics by Type (2025-2030)
11.2 Global Influenza Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Influenza Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Influenza Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Influenza Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Influenza Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Influenza Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Influenza Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Therapeutics as of 2022)
Table 10. Global Market Influenza Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Influenza Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Influenza Therapeutics Product Type
Table 13. Global Influenza Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Influenza Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Therapeutics Market Challenges
Table 22. Global Influenza Therapeutics Sales by Type (K Units)
Table 23. Global Influenza Therapeutics Market Size by Type (M USD)
Table 24. Global Influenza Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Influenza Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Influenza Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Influenza Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Influenza Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Influenza Therapeutics Sales (K Units) by Application
Table 30. Global Influenza Therapeutics Market Size by Application
Table 31. Global Influenza Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Influenza Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Influenza Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Influenza Therapeutics Market Share by Application (2019-2024)
Table 35. Global Influenza Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Influenza Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Influenza Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Influenza Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Influenza Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Influenza Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Influenza Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Influenza Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Laboratories Influenza Therapeutics Basic Information
Table 44. Abbott Laboratories Influenza Therapeutics Product Overview
Table 45. Abbott Laboratories Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Laboratories Business Overview
Table 47. Abbott Laboratories Influenza Therapeutics SWOT Analysis
Table 48. Abbott Laboratories Recent Developments
Table 49. Astrazeneca PLC Influenza Therapeutics Basic Information
Table 50. Astrazeneca PLC Influenza Therapeutics Product Overview
Table 51. Astrazeneca PLC Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Astrazeneca PLC Business Overview
Table 53. Astrazeneca PLC Influenza Therapeutics SWOT Analysis
Table 54. Astrazeneca PLC Recent Developments
Table 55. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Basic Information
Table 56. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Overview
Table 57. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics SWOT Analysis
Table 59. Biocryst Pharmaceuticals, Inc. Business Overview
Table 60. Biocryst Pharmaceuticals, Inc. Recent Developments
Table 61. Chiron Corporation Influenza Therapeutics Basic Information
Table 62. Chiron Corporation Influenza Therapeutics Product Overview
Table 63. Chiron Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Chiron Corporation Business Overview
Table 65. Chiron Corporation Recent Developments
Table 66. CSL Limited Influenza Therapeutics Basic Information
Table 67. CSL Limited Influenza Therapeutics Product Overview
Table 68. CSL Limited Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. CSL Limited Business Overview
Table 70. CSL Limited Recent Developments
Table 71. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Basic Information
Table 72. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Overview
Table 73. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Daiichi Sankyo Co., Ltd. Business Overview
Table 75. Daiichi Sankyo Co., Ltd. Recent Developments
Table 76. Glaxosmithkline PLC Influenza Therapeutics Basic Information
Table 77. Glaxosmithkline PLC Influenza Therapeutics Product Overview
Table 78. Glaxosmithkline PLC Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Glaxosmithkline PLC Business Overview
Table 80. Glaxosmithkline PLC Recent Developments
Table 81. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Basic Information
Table 82. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
Table 83. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 85. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 86. Nanotherapeutics Inc. Influenza Therapeutics Basic Information
Table 87. Nanotherapeutics Inc. Influenza Therapeutics Product Overview
Table 88. Nanotherapeutics Inc. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Nanotherapeutics Inc. Business Overview
Table 90. Nanotherapeutics Inc. Recent Developments
Table 91. Protein Sciences Corporation Influenza Therapeutics Basic Information
Table 92. Protein Sciences Corporation Influenza Therapeutics Product Overview
Table 93. Protein Sciences Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Protein Sciences Corporation Business Overview
Table 95. Protein Sciences Corporation Recent Developments
Table 96. Roche Holding AG Influenza Therapeutics Basic Information
Table 97. Roche Holding AG Influenza Therapeutics Product Overview
Table 98. Roche Holding AG Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Roche Holding AG Business Overview
Table 100. Roche Holding AG Recent Developments
Table 101. Sanofi SA Influenza Therapeutics Basic Information
Table 102. Sanofi SA Influenza Therapeutics Product Overview
Table 103. Sanofi SA Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Sanofi SA Business Overview
Table 105. Sanofi SA Recent Developments
Table 106. Shionogi and Co., Ltd. Influenza Therapeutics Basic Information
Table 107. Shionogi and Co., Ltd. Influenza Therapeutics Product Overview
Table 108. Shionogi and Co., Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Shionogi and Co., Ltd. Business Overview
Table 110. Shionogi and Co., Ltd. Recent Developments
Table 111. Sinovac Biotech Ltd. Influenza Therapeutics Basic Information
Table 112. Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
Table 113. Sinovac Biotech Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Sinovac Biotech Ltd. Business Overview
Table 115. Sinovac Biotech Ltd. Recent Developments
Table 116. Global Influenza Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Influenza Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Influenza Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Influenza Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Influenza Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Influenza Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Influenza Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Influenza Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Influenza Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Influenza Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Influenza Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Influenza Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Influenza Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Influenza Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Influenza Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Influenza Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Influenza Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Influenza Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Influenza Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Influenza Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Influenza Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Therapeutics as of 2022)
Table 10. Global Market Influenza Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Influenza Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Influenza Therapeutics Product Type
Table 13. Global Influenza Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Influenza Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Therapeutics Market Challenges
Table 22. Global Influenza Therapeutics Sales by Type (K Units)
Table 23. Global Influenza Therapeutics Market Size by Type (M USD)
Table 24. Global Influenza Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Influenza Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Influenza Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Influenza Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Influenza Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Influenza Therapeutics Sales (K Units) by Application
Table 30. Global Influenza Therapeutics Market Size by Application
Table 31. Global Influenza Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Influenza Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Influenza Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Influenza Therapeutics Market Share by Application (2019-2024)
Table 35. Global Influenza Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Influenza Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Influenza Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Influenza Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Influenza Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Influenza Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Influenza Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Influenza Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Laboratories Influenza Therapeutics Basic Information
Table 44. Abbott Laboratories Influenza Therapeutics Product Overview
Table 45. Abbott Laboratories Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Laboratories Business Overview
Table 47. Abbott Laboratories Influenza Therapeutics SWOT Analysis
Table 48. Abbott Laboratories Recent Developments
Table 49. Astrazeneca PLC Influenza Therapeutics Basic Information
Table 50. Astrazeneca PLC Influenza Therapeutics Product Overview
Table 51. Astrazeneca PLC Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Astrazeneca PLC Business Overview
Table 53. Astrazeneca PLC Influenza Therapeutics SWOT Analysis
Table 54. Astrazeneca PLC Recent Developments
Table 55. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Basic Information
Table 56. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Overview
Table 57. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics SWOT Analysis
Table 59. Biocryst Pharmaceuticals, Inc. Business Overview
Table 60. Biocryst Pharmaceuticals, Inc. Recent Developments
Table 61. Chiron Corporation Influenza Therapeutics Basic Information
Table 62. Chiron Corporation Influenza Therapeutics Product Overview
Table 63. Chiron Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Chiron Corporation Business Overview
Table 65. Chiron Corporation Recent Developments
Table 66. CSL Limited Influenza Therapeutics Basic Information
Table 67. CSL Limited Influenza Therapeutics Product Overview
Table 68. CSL Limited Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. CSL Limited Business Overview
Table 70. CSL Limited Recent Developments
Table 71. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Basic Information
Table 72. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Overview
Table 73. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Daiichi Sankyo Co., Ltd. Business Overview
Table 75. Daiichi Sankyo Co., Ltd. Recent Developments
Table 76. Glaxosmithkline PLC Influenza Therapeutics Basic Information
Table 77. Glaxosmithkline PLC Influenza Therapeutics Product Overview
Table 78. Glaxosmithkline PLC Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Glaxosmithkline PLC Business Overview
Table 80. Glaxosmithkline PLC Recent Developments
Table 81. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Basic Information
Table 82. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
Table 83. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 85. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 86. Nanotherapeutics Inc. Influenza Therapeutics Basic Information
Table 87. Nanotherapeutics Inc. Influenza Therapeutics Product Overview
Table 88. Nanotherapeutics Inc. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Nanotherapeutics Inc. Business Overview
Table 90. Nanotherapeutics Inc. Recent Developments
Table 91. Protein Sciences Corporation Influenza Therapeutics Basic Information
Table 92. Protein Sciences Corporation Influenza Therapeutics Product Overview
Table 93. Protein Sciences Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Protein Sciences Corporation Business Overview
Table 95. Protein Sciences Corporation Recent Developments
Table 96. Roche Holding AG Influenza Therapeutics Basic Information
Table 97. Roche Holding AG Influenza Therapeutics Product Overview
Table 98. Roche Holding AG Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Roche Holding AG Business Overview
Table 100. Roche Holding AG Recent Developments
Table 101. Sanofi SA Influenza Therapeutics Basic Information
Table 102. Sanofi SA Influenza Therapeutics Product Overview
Table 103. Sanofi SA Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Sanofi SA Business Overview
Table 105. Sanofi SA Recent Developments
Table 106. Shionogi and Co., Ltd. Influenza Therapeutics Basic Information
Table 107. Shionogi and Co., Ltd. Influenza Therapeutics Product Overview
Table 108. Shionogi and Co., Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Shionogi and Co., Ltd. Business Overview
Table 110. Shionogi and Co., Ltd. Recent Developments
Table 111. Sinovac Biotech Ltd. Influenza Therapeutics Basic Information
Table 112. Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
Table 113. Sinovac Biotech Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Sinovac Biotech Ltd. Business Overview
Table 115. Sinovac Biotech Ltd. Recent Developments
Table 116. Global Influenza Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Influenza Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Influenza Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Influenza Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Influenza Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Influenza Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Influenza Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Influenza Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Influenza Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Influenza Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Influenza Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Influenza Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Influenza Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Influenza Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Influenza Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Influenza Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Influenza Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Influenza Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Influenza Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Therapeutics Market Size by Country (M USD)
Figure 11. Influenza Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Influenza Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Influenza Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Influenza Therapeutics Market Share by Type
Figure 18. Sales Market Share of Influenza Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Influenza Therapeutics by Type in 2023
Figure 20. Market Size Share of Influenza Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Influenza Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Influenza Therapeutics Market Share by Application
Figure 24. Global Influenza Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Influenza Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Influenza Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Influenza Therapeutics Market Share by Application in 2023
Figure 28. Global Influenza Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Influenza Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Influenza Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Influenza Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Influenza Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Influenza Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Influenza Therapeutics Sales Market Share by Region in 2023
Figure 44. China Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Influenza Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Influenza Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Influenza Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Influenza Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Influenza Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Influenza Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Influenza Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Influenza Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Influenza Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Influenza Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Influenza Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Therapeutics Market Size by Country (M USD)
Figure 11. Influenza Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Influenza Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Influenza Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Influenza Therapeutics Market Share by Type
Figure 18. Sales Market Share of Influenza Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Influenza Therapeutics by Type in 2023
Figure 20. Market Size Share of Influenza Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Influenza Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Influenza Therapeutics Market Share by Application
Figure 24. Global Influenza Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Influenza Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Influenza Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Influenza Therapeutics Market Share by Application in 2023
Figure 28. Global Influenza Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Influenza Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Influenza Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Influenza Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Influenza Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Influenza Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Influenza Therapeutics Sales Market Share by Region in 2023
Figure 44. China Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Influenza Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Influenza Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Influenza Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Influenza Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Influenza Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Influenza Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Influenza Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Influenza Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Influenza Therapeutics Market Share Forecast by Application (2025-2030)
